An Isogenic hiPSC-Derived Model System for Establishing Gene Therapy Approaches in Alzheimer's Disease
Publication
, Conference
Wei, A; Tringali, D; Asmus, N; Yang, A; Kantor, B; Angrist, M; Chiba-Falek, O
Published in: MOLECULAR THERAPY
2020
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2020
Volume
28
Issue
4
Start / End Page
481 / 481
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wei, A., Tringali, D., Asmus, N., Yang, A., Kantor, B., Angrist, M., & Chiba-Falek, O. (2020). An Isogenic hiPSC-Derived Model System for Establishing Gene Therapy Approaches in Alzheimer's Disease. In MOLECULAR THERAPY (Vol. 28, pp. 481–481).
Wei, Angela, Domenic Tringali, Natalie Asmus, Anna Yang, Boris Kantor, Misha Angrist, and Ornit Chiba-Falek. “An Isogenic hiPSC-Derived Model System for Establishing Gene Therapy Approaches in Alzheimer's Disease.” In MOLECULAR THERAPY, 28:481–481, 2020.
Wei A, Tringali D, Asmus N, Yang A, Kantor B, Angrist M, et al. An Isogenic hiPSC-Derived Model System for Establishing Gene Therapy Approaches in Alzheimer's Disease. In: MOLECULAR THERAPY. 2020. p. 481–481.
Wei, Angela, et al. “An Isogenic hiPSC-Derived Model System for Establishing Gene Therapy Approaches in Alzheimer's Disease.” MOLECULAR THERAPY, vol. 28, no. 4, 2020, pp. 481–481.
Wei A, Tringali D, Asmus N, Yang A, Kantor B, Angrist M, Chiba-Falek O. An Isogenic hiPSC-Derived Model System for Establishing Gene Therapy Approaches in Alzheimer's Disease. MOLECULAR THERAPY. 2020. p. 481–481.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2020
Volume
28
Issue
4
Start / End Page
481 / 481
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences